Breakthrough SARS-CoV-2 infections after vaccination: A critical
review
Zeinab Mohseni Afshar1, Mohammad
Barary2, Feizollah Mansouri1, Soheil
Ebrahimpour3, Kosar Nazary2, Terence
T. Sio4, Mark J. M. Sullman5,6,
Kristin Carson-Chahhoud7, Arefeh
Babazadeh3, *
1- Clinical Research Development Center, Imam Reza Hospital, Kermanshah
University of Medical Sciences, Kermanshah, Iran.
2- Student Research Committee, Babol University of Medical Sciences,
Babol, Iran
3- Infectious Diseases and Tropical Medicine Research Center, Health
Research Institute, Babol University of Medical Sciences, Babol, Iran.
4- Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA
5- Department of Social Sciences, University of Nicosia, Nicosia, Cyprus
6- Department of Life and Health Sciences, University of Nicosia,
Nicosia, Cyprus
7- Australian Centre for Precision Health, University of South
Australia, Adelaide, Australia
Correspondence: Arefeh Babazadeh, Infectious Diseases and
Tropical Medicine Research Center, Health Research Institute, Babol
University of Medical Sciences, Babol, Iran. Tel: +989113133397, Fax:
+981132207918, Email: drbabazadeh.a@yahoo.com